Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157:H7

FEMS Immunology and Medical Microbiology

Volumn 19, Issue 1, 1997, Pages 57-64

  Yoh, M ^a   Frimpong, E K ^a   Honda, T ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Antimicrobial agent; Fosfomycin; O157:H7; Vero toxin

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFAZOLIN; DOXYCYCLINE; FOSFOMYCIN; GENTAMICIN; MINOCYCLINE; STREPTOMYCIN; VEROTOXIN;

ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; JAPAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TOXIN SYNTHESIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; BIOLOGICAL ASSAY; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA, CONDITIONED; CYTOTOXICITY TESTS, IMMUNOLOGIC; DISEASE OUTBREAKS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; FOSFOMYCIN; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; SHIGA-LIKE TOXIN I; VERO CELLS;

EID: 0030770055     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(97)00050-3     Document Type: Article

References (14)

1. Karmali, M.A., Petric, M., Lim, C., Fleming, P.C., Arbus, G.S. and Lior, H. (1985) The association between hemolytic uremic syndrome and infection by Verotoxin-producing Escherichia coli. J. Infect. Dis. 151, 775-782.
2. Karmali, M.A., Steele, B.T., Petric, M. and Lim, C. (1983) Sporadic cases of hemolytic uremic syndrome associated with fecal cytotoxin and cytotoxin-producing Escherichia coli. Lancet I, 619-620.
3. NIHJ and Ministry of Health and Welfare (1996) VT1991.1-1995.11. Infect. Agents Surveill. Rep. 17, 1-2.
4. Griffin, P.M. and Tauxe, R.V. (1991) The epidemiology of infections caused by Escherichia coli O157:H7, other enterohaemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 13, 60-98.
5. Ostroff, S.M., Kobayashi, J.M. and Lewis, J.H. (1989) Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. J. Am. Med. Assoc. 262, 355-359.
6. Walterspiel, J.N., Ashkenazi, S., Morrow, A.L. and Cleary, T.G. (1992) Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection 20, 25-29.
7. Mundell, D.H., Anselmo, C.R. and Wishnow, R.M. (1976) Factors influencing heat-labile Escherichia coli enterotoxin activity. Infect. Immun. 14, 383-388.
8. Ishiyama, M., Shiga, M., Sasamoto, K., Mizoguchi, M. and He, P. (1993) A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye. Chem. Pharm. Bull. 41, 1118-1122.
9. +: the implication of a protective role of B-crystalline accumulation in reactive glia. Brain Res. 673, 47-52.
10. Carlone, N.A., Cattaneo, O., Cuffini, A.M. and Ferrero, M. (1980) Effects of subinhibiting concentrations of fosfomycin on the ultrastructure of E. coli K126. G. Batteriol. Virol. Immunol. 73, 260-271.
11. National Committee for Clinical Standards (1990) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd Edn. Approved standard. NCCLS Document M7-A2, Villanova, PA.
12. O'Brien, A.D. and Holmes, R.K. (1987) Shiga and Shiga-like toxins. Microbiol. Rev. 51, 206-220.
13. Head, S.C., Petric, M., Richardson, S., Roscoe, M. and Karmali, M.A. (1988) Purification and characterization of verotoxin 2. FEMS Microbiol. Lett. 51, 211-216.
14. Tarr, P.I., Fouser, L.S., Stapleton, A.E. et al. (1996) Hemolytic-uremic syndrome in a six-year old girl after a urinary tract infection with shiga-toxin-producing Escherichia coli O103:H2. New Engl. J. Med. 335, 635-638.